Chronic blockade of hindbrain glucocorticoid receptors reduces blood pressure responses to novel stress and attenuates adaptation to repeated stress

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 296, Issue 5, 2009, Pages

  Bechtold, Andrea G ^a   Patel, Gina ^b   Hochhaus, Guenther ^b   Scheuer, Deborah A ^c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF FLORIDA HEALTH   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF FLORIDA   (United States)

Author keywords

Brain; Chronic stress; Corticosterone; Hypothalamic pituitary adrenal axis; Nucleus of the solitary tract

Indexed keywords

CORTICOSTERONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; MIFEPRISTONE;

ADAPTATION; ADRENAL GLAND; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; BODY WEIGHT; BORDERLINE HYPERTENSION; CARDIOVASCULAR RESPONSE; CHRONIC STRESS; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; HEART RATE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PHYSICAL STRESS; PRIORITY JOURNAL; RAT; RHOMBENCEPHALON;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; BLOOD PRESSURE; BODY WEIGHT; CORTICOSTERONE; DISEASE MODELS, ANIMAL; HEART RATE; HORMONE ANTAGONISTS; HYPERTENSION; MALE; MIFEPRISTONE; RATS; RATS, INBRED WKY; RATS, SPRAGUE-DAWLEY; RECEPTORS, GLUCOCORTICOID; RHOMBENCEPHALON; STRESS, PHYSIOLOGICAL;

EID: 66149144703     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00095.2008     Document Type: Article

References (71)

1. Agyemang C, van Hooijdonk C, Wendel-Vos W, Ujcic-Voortman JK, Lindeman E, Stronks K, Droomers M. Ethnic differences of environmental stressors on blood pressure and hypertension in the Netherlands. BMC Public Health doi: 10.1186/1471-2458-11118
2. Bing SH, Wang HL, Leenen FHH. Chronic central infusion of aldoseterone leads to sympathetic hyperactivity and hypertension in Dahl S but not Dahl R rats. Am J Physiol Heart Circ Physiol 288: H517-H524, 2005.
3. Branth S, Ronquist G, Stridsberg M, Hambraeus L, Kindgren E, Olsson R, Carlander D, Arnetz B. Development of abdominal fat and incipient metabolic syndrome in young healthy men exposed to long-term stress. Nutr Metab Cardiovasc Dis 17: 427-435, 2007. (Pubitemid 47069914)
4. Buller K, Xu Y, Dayas C, Day T. Dorsal and ventral medullary catecholamine cell groups contribute differentially to systemic interleukin-1β- induced hypothalamic pituitary adrenal axis responses. Neuroendocrinology 73: 129-138, 2001. (Pubitemid 32217873)
5. Chrousos GP, Kino T. Glucocorticoid action networks and complex psychiatric and/or somatic disorders. Stress 10: 213-219, 2007. (Pubitemid 46789478)
6. Cook CJ. Glucocorticoid feedback increases the sensitivity of the limbic system to stress. Physiol Behav 75: 455-464, 2002.
7. Dallman MF. Stress update: adaptation of the hypothalamic-pituitary- adrenal axis to chronic stress. Trends Endocrinol Metab 4: 62-69, 1993.
8. Dallman MF, Akana SF, Scribner KA, Bradbury MJ, Walker CD, Strack AM. Stress, feedback and facilitation in the hypothalamo-pituitary- adrenal axis. J Neuroendocrinol 4: 517-526, 1992.
9. Dallman MF, Pecoraro N, Akana SF, la Fleur SE, Gome F, Houshyar H, Bell ME, Bhatnagar S, Laugero KD, Manalo S. Chronic stress and obesity: a new view of "comfort food". Proc Natl Acad Sci USA 100: 11696-11701, 2003.
10. Dayas CV, Buller KM, Crane JW, Xu Y, Day TA. Stressor categorization: acute physical and psychological stressors elicit distinctive recruitment patterns in the amygdala and in medullary noradrenergic cell groups. Eur J Neurosci 14: 1143-1152, 2001. (Pubitemid 35463758)
11. Dayas CV, Buller KM, Day TA. Medullary neurons regulate hypothalamic corticotropin-releasing factor cell responses to an emotional stressor. Neuroscience 105: 707-719, 2001.
12. de Kloet RE, Joels M, Holsboer F. Stress and the brain: from adaptation to disease. Nat Rev 6: 463-475, 2005. (Pubitemid 40769171)
13. De Vogli R, Ferrie JE, Chandola T, Kivmaki M, Marmot MG. Unfairness and health: evidence from the Whitehall II study. J Epidemiol Community Health 61: 513-518, 2007. (Pubitemid 46799553)
14. DeRijk R, de Kloet R. Corticosteroid receptor genetic polymorphisms and stress responsivity. Endocrine 28: 263-269, 2005. (Pubitemid 43042724)
15. Deter HC, Bleecher A, Weber CS. Cardiovascular reactivity of patients with essential and renal hypertension in an emotion-triggering interview. Behav Med 32: 117-125, 2007.
16. Duma D, Jewell CM, Cidlowski JA. Multiple glucocorticoid receptor isoforms and mechanisms of post-translational modification. J Steroid Biochem Mol Biol 102: 11-21, 2006.
17. Esler M, Eikelis N, Schlaich M, Lambert G, Alvarenga M, Kaye D, El-Osta A, Guo L, Barton D, Pier C, Brenchley C, Dawood T, Jennings G, Lambert E. Human sympathetic nerve biology. Parallel influences of stress and epignentics in essential hypertension and panic disorder. Ann NY Acad Sci 1148: 338-348, 2008.
18. Francis AB, Pace TWW, Ginsberg AB, Rubin BA, Spencer RL. Limited brain diffusion of the glucocorticoid receptor agonist RU28362 following ICV administration: implications for ICV drug delivery and glucocorticoid negative feedback in the hypothalamic-pituitary-adrenal axis. Neuroscience 141: 1503-1515, 2006.
19. Francis J, Weiss RM, Wei SG, Johnson AK, Beltz TG, Zimmerman K, Felder RB. Central mineralocorticoid receptor blockade improves volume regulation and reduces sympathetic drive in heart failure. Am J Physiol Heart Circ Physiol 281: H2241-H2251, 2001. (Pubitemid 33121771)
20. Friese RS. Common genetic mechanisms of blood pressure elevation in two independent rodent models of human essential hypertension. Am J Hypertens 18: 633-652, 2005.
21. Fuchs LC, Hoque AM, Clarke NL. Vascular and hemodynamic effects of behavioral stress in borderline hypertensive and Wistar-Kyoto rats. Am J Physiol Regul Integr Comp Physiol 274: R375-R382, 1998.
22. Funder JW. Mineralocorticoids, glucocorticoids, receptors and response elements. Science 259: 1132-1133, 1993.
23. Gaillard RC, Riondel A, Muller AF, Herrmann W, Baulieu EE. RU 486: A steroid with antiglucocorticosteroid activity that only disinhibits the human pituitary-adrenal system at a specific time of day. Proc Natl Acad Sci USA 81: 3879-3882, 1984. (Pubitemid 14087822)
24. Gieroba ZJ, Fullerton MJ, Funder JW, Blessing WW. Medullary pathways for adrenocorticotropic hormone and vasopressin secretion in rabbits. Am J Physiol Regul Integr Comp Physiol 262: R1047-R1056, 1992.
25. Gomez-Sanchez EP. Intracerebroventricular infusion of aldosterone induces hypertension in rats. Endocrinology 118: 819-823, 1986.
26. Gomez-Sanchez EP, Venkataraman MT, Thwaites D, Fort C. ICV infusion of corticosterone antagonizes ICV-aldosterone hypertension. Am J Physiol Endocrinol Metab 258: E649-E653, 1990. (Pubitemid 20142346)
27. Grunfeld JP, Eloy L. Glucocorticoids modulate vascular reactivity in the rat. Hypertension 10: 608-618, 1987. (Pubitemid 18065141)
28. Hammer F, Stewart PM. Cortisol metabolism in hypertension. Best Practice Res Clin Endocrinol Metabol 20: 337-353, 2006. (Pubitemid 44356450)
29. Harfstrand A, Fuxe K, Cintra A, Agnati LF, Zini I, Wikstrom AC, Okret S, Yu ZY, Goldstein M, Steinbusch H, Verhofstad A, Gustafsson JA. Glucocorticoid receptor immunoreactivity in monoaminergic neurons of rat brain. Proc Natl Acad Sci USA 83: 9779-9783, 1986. (Pubitemid 17223440)
30. Huerta C, Lanes SF, Rodriguez LAG. Respiratory medications and the risk of cardiac arrhythmias. Epidemiology 16: 360-366, 2005. (Pubitemid 40586712)
31. Izzo JI, Black HR. Hypertension Primer (3rd ed.). Philadelphia, PA: Lippincott, Williams & Wilkins, 2003.
32. Kreek MJ, Nielsen DA, Butelman ER, LaForge KS. Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction. Nat Neurosci 8: 1450-1457, 2005.
33. Kvetnansky R, Pacak K, Fukahara K, Viskupic E, Hiremagalur B, Nankova B, Goldstein DS, Sabban EL, Kopin IJ. Sympathoadrenal system in stress, interaction with the hypothalamic-pituitary-adrenocortical system. Ann NY Acad Sci 771: 131-158, 1995. (Pubitemid 26077402)
34. Laugero KD, Gomez F, Manalo S, MFD. Corticosterone infused intracerebroventricularly inhibits energy storage and stimulates the hypothalamo-pituitary axis in adrenalectomized rats drinking sucrose. Endocrinology 143, 2002. (Pubitemid 35397596)
35. Lin RCY, Wang XL, Morris BJ. Association of coronary artery disease with glucocorticoid receptor N363S variant. Hypertension 41: 404-407, 2003.
36. Lin RCY, Wang YSW, Morris BJ. Association and linkage analyses of glucocorticoid receptor gene markers in essential hypertension. Hypertension 34: 1186-1192, 1999.
37. Loewy AD, Spyer KM. Central regulation of autonomic functions. New York: Oxford University Press, 1990, p. 390.
38. Lupien SJ, King S, Meany MJ, McEwen BS. Can poverty get under your skin? Basal cortisol levels and cognitive function in children from low and high socioeconomic status. Dev Psychopathol 13: 653-676, 2001. (Pubitemid 33406348)
39. Magiakou MA, Smyrnaki P, Chrousos GP. Hypertension in Cushing's syndrome. Best Practice Res Clin Endocrinol and Metab 20: 467-482, 2006. (Pubitemid 44382381)
40. Matta SG, Foster CA, Sharp BM. Selective administration of nicotine into catecholaminergic regions of rat brainstem stimulates adrenocorticotropin secretion. Endocrinology 133: 2935-2942, 1993.
41. McDougall SJ, Paull JRA, Widdop RE, Lawrence AJ. Restraint stress: differential cardiovascular responses in Wistar-Kyoto and spontaneously hypertensive rats. Hypertension 35: 126-129, 2000.
42. Ohlin B, Goran B, Rosvall M, Nilsson PM. Job strain in men, but not women, predicts a significant rise in blood pressure after 65 years of follow-up. J Hypertens 25: 525-531, 2007. (Pubitemid 46213789)
43. Ottenweller JE, Servatius RJ, Natelson BH. Repeated stress persistently elevates morning, but not evening, plasma corticosterone levels in male rats. Physiol Behav 55: 337-340, 1994.
44. Palmer AA, Printz MP. Strain differences in fos expression following airpuff startle in spontaneously hypertensive and Wistar Kyoto rats. Neuroscience 89: 965-978, 1999.
45. Rajpert EJ, Lemaigre FP, Eliard PH, Place M, Lafontaine DA, Economidis IV, Belayew A, Martial JA, Rousseau GG. Glucocorticoid receptors bound to the antagonist RU486 are not downregulated despite their capacity to interact in vitro with defined gene regions. J Steroid Biochem 26: 513-520, 1987.
46. Rashid S, Lewis G. The mechanisms of differential glucocorticoid and mineralocorticoid action in the brain and peripheral tissue. Clin Biochem 38: 401-409, 2005. (Pubitemid 40501522)
47. Roozendaal B, Williams CL, McGaugh JL. Glucocorticoid receptor activation in the rat nucleus of the solitary tract facilitates memory consolidation: involvement of the basolateral amygdala. Eur J Neurosci 11: 1317-1323, 1999. (Pubitemid 29142191)
48. Rosmond R, Chagnon YC, Holm G, Chagnon M, Perusse L, Lindell K, Carlsson B, Bouchard C, Bjorntorp P. A glucocorticoid receptor gene marker is associated with abdominal obesity, leptin, and dysregulation of the hypothalamic-pituitary- adrenal axis. Obes Res 8: 211-218, 2000.
49. Rossi R, Tauchmanova L, Luciano A, Di Martino M, Battista C, Del Viscovo L, Nuzzo V, Lombardi G. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features. J Clin Endocrinol Metab 85: 1440-1448, 2000. (Pubitemid 32289484)
50. Ruch W, Baumann JB, Hausler A, Otten UH, Siegl H, Girard J. Importance of the adrenal cortex for development and maintenance of hypertension in spontaneously hypertensive rats. Acta Endocrinol 105: 417-424, 1984. (Pubitemid 14193134)
51. Sanders BJ, Lawler JE. The borderline hypertensive rat (BHR) as a model for environmentally-induced hypertension: a review and update. Neurosci Biobehav Rev 16: 207-217, 1992.
52. Sapolsky RM, Romero LM, Munck AU. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory and preparative actions. Endocrine Rev 21: 55-89, 2000.
53. Scheuer DA, Bechtold AG. Glucocorticoids modulate baroreflex control of heart rate in conscious normotensive rats. Am J Physiol Regul Integr Comp Physiol 282: R475-R483, 2002.
54. Scheuer DA, Bechtold AG. Glucocorticoids potentiate central actions of angiotensin to increase arterial pressure. Am J Physiol Regul Integr Comp Physiol 280: R1719-R1726, 2001.
55. Scheuer DA, Bechtold AG, Shank SS, Akana SF. Glucocorticoids act in the dorsal hindbrain to increase arterial pressure. Am J Physiol Heart Circ Physiol 286: H458-H467, 2004.
56. Scheuer DA, Bechtold AG, Vernon KA. Chronic activation of dorsal hindbrain corticosteroid receptors augments the arterial pressure response to acute stress. Hypertension 49: 127-133, 2007.
57. Stamp J, Herbert J. Corticosterone modulates autonomic responses and adaptation to immediate-early gene expression to repeated restraint. Neuroscience 107: 465-479, 2001. (Pubitemid 33079122)
58. Steptoe A, Kunz-Ebrecht S, Owen N, Feldman PJ, Willemsen G, Kirschbaum C, Marmot MG. Socioeconomic status and stress-related biological responses over the working day. Psychosom Med 65: 461-470, 2003.
59. Takahashi H, Takeda K, Ashizawa H, Inoue A, Yoneda S, Yoshimura M, Ijichi H. Centrally induced cardiovascular and sympathetic responses to hydrocortisone in rats. Am J Physiol Heart Circ Physiol 245: H1013-H1018, 1983.
60. Tonolo G, Soro A, Madeddu P, Troffa C, Melis MG, Patteri G, Pinna Parpaglia P, Sabino G, Maioli M, Glorioso N. Effect of chronic intracerebroventricular dexamethasone on blood pressure in normotensive rats. Am J Physiol Endocrinol Metab 264: E843-E847, 1993.
61. Ukkola O, Rosmond R, Tremblay A, Bouchard C. Glucocorticoid receptor Bcl I variant is associated with an increased atherogenic profile in response to long-term overfeeding. Atherosclerosis 157: 221-224, 2001. (Pubitemid 32539374)
62. van Acker SA, Fluttert MF, Sibug RM, de Kloet ER. Intracerebroventricular administration of a glucocorticoid receptor antagonist enhances the cardiovascular responses to brief restraint. Eur J Pharmacol 430: 87-91, 2001.
63. Van den Berg DTWM, De Jong W, de Kloet ER. Mineralocorticoid antagonist inhibits stress-induced blood pressure response after repeated daily warming. Am J Physiol Endocrinol Metab 267: E921-E926, 1994.
64. van den Buuse M, van Acker SA, Fluttert MF, de Kloet ER. Involvement of corticosterone in cardiovascular responses to an open-field novelty stressor in freely moving rats. Physiol Behav 75: 207-215, 2002.
65. van der Hooft CS, Heeringa J, Brusselle GG, Hofman A, Witteman JCM, Kingma JH, Sturkenboom MCJM, Stricker BHC. Corticosteroids and the risk of atrial fibrillation. Arch Intern Med 165: 1016-1020, 2006.
66. van Haarst AD, Oitzl MS, Workel JO, de Kloet ER. Chronic brain glucocorticoid receptor blockade enhances the rise in circadian and stress-induced pituitary-adrenal activity. Endocrinology 137: 4935-4943, 1996.
67. Walker BR. Glucocorticoids and cardiovascular disease. Eur J Endocrinol 157: 545-559, 2007.
68. Wang HX, Leineweber C, Kirkeeide R, Svane B, Schenck-Gustafsson K, Theorell T, Orth-Gomer K. Psychosocial stress and atherosclerosis: family work and stress accelerate progression of coronary disease in women. The Stockholm female coronary angiography study. J Intern Med 261: 245-254, 2006.
69. Wang LL, Ou CC, Chan JYH. Receptor-independent activation of GABAergic neurotransmission and receptor-dependent nontranscriptional activation of phosphatidylinositol 3-kinase/protein kinase Akt pathway in short-term cardiovascular actions of dexamethasone at the nucleus tractus solitarii of the rat. Mol Pharmacol 67: 489-498, 2005.
70. Watt GCM, Harrap SB, Foy CJW, Holton DW, Edwards HV, Davidson HR, Conner JM, Lever AF, Fraser R. Abnormalities of glucocorticoid metabolism and the renin-angiotensin system: a four-corners approach to the identification of genetic determinants of blood pressure. J Hypertens 10: 473-482, 1992.
71. Whitworth JA, Mangos GJ, Kelley JJ. Cushing, cortisol and cardiovascular disease. Hypertension 36: 912-916, 2000.